ROWEEPRA XR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is Levetiracetam.
| Product ID | 69102-200_601eaa2b-5c17-74c6-e053-2991aa0a1123 | 
| NDC | 69102-200 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ROWEEPRA XR | 
| Generic Name | Levetiracetam | 
| Dosage Form | Tablet, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-12-22 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA202095 | 
| Labeler Name | OWP Pharmaceuticals, Inc. | 
| Substance Name | LEVETIRACETAM | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2018-01-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA202095 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-01-30 | 
| Ingredient | Strength | 
|---|---|
| LEVETIRACETAM | 500 mg/1 | 
| SPL SET ID: | eb66dee6-1d92-4b2d-ae4a-232faf129f24 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 69102-201 | ROWEEPRA XR | ROWEEPRA XR | 
| 69102-200 | ROWEEPRA XR | ROWEEPRA XR | 
| 0054-0224 | Levetiracetam | Levetiracetam | 
| 0121-0799 | Levetiracetam | LEVETIRACETAM | 
| 0121-1598 | Levetiracetam | LEVETIRACETAM | 
| 0121-2397 | Levetiracetam | LEVETIRACETAM | 
| 0121-4799 | Levetiracetam | LEVETIRACETAM | 
| 0121-4802 | LEVETIRACETAM | LEVETIRACETAM | 
| 0143-9574 | Levetiracetam | Levetiracetam | 
| 0143-9673 | Levetiracetam | Levetiracetam | 
| 0228-2167 | Levetiracetam | Levetiracetam | 
| 0378-5613 | Levetiracetam | levetiracetam | 
| 0378-5615 | Levetiracetam | levetiracetam | 
| 0378-5617 | Levetiracetam | levetiracetam |